Jamy Ard received research support from Nestle Healthcare Nutrition, Eli Lilly and Company, Boehringer Ingelheim, Epitomee, Inc., UnitedHealth Group R&D, KVKTech, WW and Novo Nordisk and is a consultant for Nestle Healthcare Nutrition, Eli Lilly and Company, Optum Labs R&D, Novo Nordisk, Intuitive, Regeneron, Brightseed, Amplifier Therapeutics, Amgen and Ingredion. Dr. Ard is an advisory board member for Novo Nordisk, Nestle Healthcare Nutrition, Eli Lilly and Company, WW and Boehringer Ingelheim. He is a member of the International Food Information Council—Assembly, The Obesity Society—President 2024, American Diabetes Association, Society of Behavioural Medicine, Roundtable on Obesity Solutions, American Society for Nutrition and American Society for Nutrition Foundation—Board of Trustees Executive Committee. Kimberly Gudzune was an Associate Professor in the Department of Medicine at the Johns Hopkins University School of Medicine and engaged in this research as a private advisor and not in her capacity as a Johns Hopkins faculty member. She received no compensation for this work. She has received personal fees for participation on advisory boards for Eli Lilly and Company and Novo Nordisk and travel support from Eli Lilly and Company and Novo Nordisk. Her former institution (Johns Hopkins) received grant funding from Novo Nordisk. Since the initial conduct of this research, Dr. Gudzune reports being an employee of the American Board of Obesity Medicine Foundation. Brandi Addison is a speaker for Eli Lilly and Company, Novo Nordisk and Corcept Therapeutics and is an advisory board member for Eli Lilly and Company. She is a member of the American Association of Clinical Endocrinology and The Obesity Society. Ildiko Lingvay received research funding (paid to institution) and/or products from Novo Nordisk, Sanofi, Boehringer‐Ingelheim, Dexcom and received research‐related consulting fees (paid to institution) from Novo Nordisk. She received advisory/consulting fees and/or other support from: AbbVie, Altimmune, Alveus Therapeutics, Amgen, Antag Therapeutics, AstraZeneca, Bayer, Betagenon AB, Bioio Inc., Biomea, Boehringer‐Ingelheim, Carmot, Cytoki Pharma, Eli Lilly and Company, Intercept, Janssen/J&J, Juvena, Keros Therapeutic, Inc., Mediflix, Merck, Metsera, Neurocrine, Novo Nordisk, Pharmaventures, Pfizer, Regeneron, Roche, Sanofi, Shionogi, Source Bio, Structure Therapeutics, TARGET RWE, TERNS Pharma, The Comm Group, WebMD and Zealand Pharma. Clare J. Lee, Dachuang Cao, Casey J. Mast, Adam Stefanski, Beverly Falcon and Donna Mojdami are employees and shareholders of Eli Lilly and Company.
PubMed
